NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
NOTE
This title is currently only available in Bookshelf in PDF format (2.7M). The full-text online version of this publication is forthcoming.
Guideline version (Final)
Evidence reviews underpinning recommendations 1.3.1 to 1.3.5, 1.3.23 to 1.3.29, and 1.3.38 to 1.3.61 and research recommendations in the NICE guideline
Disclaimer: The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.
NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive. All NICE guidance is subject to regular review and may be updated or withdrawn.
- Review [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].[Internist (Berl). 2017]Review [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].Kalscheuer H, Serfling G, Schmid S, Lehnert H. Internist (Berl). 2017 Oct; 58(10):1020-1028.
- An atypical hyperosmolar hyperglycemic state and diabetic ketoacidosis induced by sodium-glucose cotransporter-2 inhibitors: A case report.[J Formos Med Assoc. 2020]An atypical hyperosmolar hyperglycemic state and diabetic ketoacidosis induced by sodium-glucose cotransporter-2 inhibitors: A case report.Wang CT, Chang CW, Lu YC, Lam HC, Ku SJ, Tseng KB, Kao YH. J Formos Med Assoc. 2020 Aug; 119(8):1325-1328. Epub 2019 Dec 5.
- Review Toxicology of Medications for Diabetes Mellitus.[Crit Care Clin. 2021]Review Toxicology of Medications for Diabetes Mellitus.Baumgartner K, Devgun J. Crit Care Clin. 2021 Jul; 37(3):577-589.
- Review The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.[Expert Opin Pharmacother. 2015]Review The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.Munir KM, Davis SN. Expert Opin Pharmacother. 2015; 16(15):2331-41. Epub 2015 Sep 4.
- Review [Drug treatment of type 2 diabetes].[Presse Med. 2007]Review [Drug treatment of type 2 diabetes].Tielmans A, Laloi-Michelin M, Coupaye M, Virally M, Meas T, Guillausseau PJ. Presse Med. 2007 Feb; 36(2 Pt 2):269-78. Epub 2006 Dec 11.
- Evidence review for glucose-lowering agents for managing blood glucose levels in...Evidence review for glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes
Your browsing activity is empty.
Activity recording is turned off.
See more...